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1. Introduction 
(-)Hydroxycitrate, an inhibitor of citrate cleavage 
enzyme (EC 4.1.3.8) [l] inhibits fatty acid synthesis 
in rat liver [2] . This effect is likely to result from a 
shortage of cytoplasmic acetyl-CoA. Whereas fatty 
acid synthesis is considered an extramitochondrial 
process, formation of HMG-CoA serving as precursor 
of mevalonate may be catalyzed by mitochondrial 
HMG-CoA synthase (EC 4.1.3.5) or by an extramito- 
chondrial pathway, e.g. [3] . 
In this paper an inhibition of hepatic cholesterol 
and fatty acid synthesis by (-)-hydroxycitrate in the 
isolated perfused rat liver is reported; acetate 
reversed the effect on fatty acid synthesis. In cell-free 
extracts of rat liver (-)-hydroxycitrate is shown not to 
influence cholesterol formation itself but to be a 
potent stimulator of fatty acid from 14C-acetate. 
These experiments are taken as evidence of a 
physiologically important extramitochondrial pathway 
from acetyl-CoA to mevalonate in rat liver. 
2. Methods 
For measuring fatty acid [4] and cholesterol syn- 
thesis by the ‘HOH-method, livers of male Buffalo 
rats (150 g) were perfused as described extensively 
elsewhere [5] . The medium contained in 100 ml 
Krebs-Henseleit buffer: 2.5 g albumin reinst 
(Behringwerke AC, Frankfurt/Main, West Germany), 
0.55 mmole glucose, 4 mg ampicillin and amin’o acids 
corresponding to steady state levels observed in liver 
North-Holland Pu blishing Company - Amsterdam 
perfusions [6] . Assays with cell-free extracts were 
performed according to [7]. ATP was determined 
after freeze-clamping of the perfused liver [8], citrate 
in deproteinized homogenates [9], and acetoacetate 
plus 3-hydroxybutyrate were analyzed in the per- 
fusion medium [lo] . Samples of (-)-hydroxycitric 
acid lactone were kindly supplied by Dr. Y .S. Lewis, 
Mysore, India, and by Dr. H. Lengsfeld (Hoffman-La 
Roche, Base& Switzerland). The lactone was hydro- 
lyzed according to [2] before use. 
3. Results 
3.1. Perfusion experiments 
Fatty acid and cholesterol synthesis were inhibited 
in a similar manner by different (-)-hydroxycitrate 
concentrations (fig. 1). As in uivo [2], this compound 
appears to only partially inhibit fatty acid synthesis 
in the perfused organ. 
ATP levels of liver tissue perfused for 60 min with 
different concentrations of (-)-hydroxycitrate 
remained in the control range. In the presence of 0.44, 
1 .l, and 2.2 mM (-)-hydroxycitrate, ATP contents of 
2.8 +- 0.9,2.61 f 0.49, and 2.65 f 0.07 pmoles/g wet 
weight (+S.D.), respectively, were found as compared 
to 2.88 + 0.41 at the end of the control periods. 
Ketone body production (acetoacetate plus 
3-hydroxybutyrate) by perfused liver was not 
changed in the presence of 1 .l mM (-)-hydroxy- 
citrate. It amounted to 8.35 + 5.15 moles/g liver, 
wet weight X hr (2S.D.) as compared to 9.25 f 4.8 
pmoles/g liver, wet weight X hr in control experiments. 
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Fig. 1. Influence of (-)-hydroxycitrate on the rate of 
cholesterol and fatty acid synthesis in perfused rat liver. 40 
min after operation (9:00 hr) 3H-water was added to the 
perfusion medium (final specific activity 15,000 dpm/patom 
hydrogen). 30 min thereafter a control liver sample was taken. 
(-)-Hydroxycitrate was added and perfusion continued for 
another 60 min, after which 2 additional liver samples were 
taken and saponified. The non-saponifiable fraction was 
washed twice (HaO) and treated with digitonine (cholesterol). 
The fatty acids were extracted after acidification and washed 
with Ha0 (1X) and 0.2 N CHsCOOH in 20% ethanol (2X). 
Ordinates: Controls represent averages of all control periods. 
The other values have been calculated from the increments 
of 3H-incorporation during the f(-)-hydroxycitrate periods. 
3H-incorporation into lipids was previously shown to be 
linear during 90 min. Vertical bars, S.E.M. 
3.2. Acetate effect 
Studies on the subcellular localization of acetyl- 
CoA synthetase (EC 6.2.1.1) revealed that acetate is a 
citrate-independent precursor of cytoplasmic acetyl. 
CoA [ 111. Acetate uptake by the perfused rat liver 
amounted to about 50 pmoles/g liver, wet weight 
X hr, if its medium concentration was higher than 10 
mM [51- 
Fig. 2 shows that the simultaneous addition of 
(-)-hydroxycitrate and 10 mh4 acetate increased fatty 
acid synthesis to 150% of the uninhibited rate. The 
reversion by acetate indicates that (-)-hydroxycitrate 
inhibition of fatty acid synthesis is mediated by a 
shortage of cytoplasmic acetyl-CoA. On the other 
hand, the inhibition of cholesterol synthesis was not 
relieved by acetate addition (fig. 2). Therefore, an 
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Fig. 2. Influence of acetate on (-)-hydroxycitrateinhibition 
of cholesterol and fatty acid synthesis in perfused rat liver. 
Experimental design as in fig. 1. At 30 min, 10 mM acetate 
and 1.1 mM (-)-hydroxycitrate were added to the perfusion 
medium. This concentration of acetate was shown not to 
influence 3H-incorporation into liver lipids [S] . The synthetic 
rates after acetate + hydroxycitrate addition (30-90 min) are 
shown as percentages of control periods (O-30 min). White 
columns: fatty acid synthesis; black columns: cholesterol 
synthesis. *20 mM acetate. 
additional effect of (-)-hydroxycitrate on cholesterol 
synthesis had to be considered. 
3.3. Experiments with cell-free extracts 
Addition of (-)-hydroxycitrate to a 10,OOOg 
supernatant of rat liver increased the rate of 
l-‘4C-acetate incorporation into fatty acids consider- 
ably with a concomitant slight inhibition of its in- 
corporation into cholesterol. If fatty acid synthesis 
was lowered by avidin to subnormal rates, however, 
formation of labeled cholesterol was not inhibited by 
(-)-hydroxycitrate (fig. 3). This was corroborated in 
other experiments where 1-14C-acetate incorporation 
into cholesterol in the presence of both 1.33 mM 
(-)-hydroxycitrate and 1 U/ml avidin (7470 f 168 
dpm/assay) was the same as in the controls 
(7776 5 211 dpm/assay) (n = 4; mean +S.EM.). 
Previous dialysis of the homogenate did not change 
the response of fatty acid synthesis to (-)-hydroxy- 
citrate (fig. 3). As less than 0.01 mM citrate was 
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Fig. 3. Influence of (-)-hydroxycitrate and avidin on 
1-14C-acetate incorporation into cholesterol and fatty acids 
by 10,000 g supernatant of rat liver. In each of the 4 
experiments, livers from 2 male Wistar rats (200 g) were 
forced through a sieve. Homogenization: 6 strokes (300 rpm) 
in a loose-fitting Potter-Elvehjem homogenizer with 2.5 vol/g, 
wet weight of a medium, containing’81 mM potassium phos 
phate, pH 7.4; 5 mM MgCl2; 37 mM nicotinamide. Assay 
mixture, see Methods. Start by addition of 10 mM 1-14C 
acetate (specific activity 130,000 dpm/Mmole) after gassing 
10 min at 0” with 95% 02:5% CO2. For analytical methods 
see fig. 1. Columns: AV denotes 10 min preincubation with 
1 U/ml avidin. 1-i: controls without additions. Addition of 
(-)-hydroxycitrate: 0.53 mM, fZl; 1.33 mM, 6111; 2.66 mM, 
1. Vertical bars: range of duplicate assays. a) 10,000 g 
supernatant; b) supernatant dialysed twice (30 min each) 
against 500 ml of the above medium + 20 mM cysteine. 
present at 0 and 60 min of the incubation period, it is 
concluded that (-)-hydroxycitrate rather than 
endogenous citrate is responsible for the stimulatory 
effect. 
4. Discussion References 
The similarity of the (-)-hydroxycitrate effect on 
cholesterol and fatty acid synthesis is suggestive of a 
common mechanism of inhibition, e.g. lowering of the 
cytoplasmic acetyl-CoA level. This assumption requires 
that both effects be abolished by replenishment of the 
acetyl-CoA pool by exogenous acetate. While this was 
verified for fatty acid synthesis, 3H-incorporation into 
cholesterol was not normalized by acetate addition. 
Experiments with cell-free extracts, however, 
demonstrated that 14C-acetate incorporation into 
cholesterol was not inhibited if acetyl-CoA consump- 
tion by fatty acid synthesis was blocked by avidin 
(fig. 3). Moreover, they revealed a considerable stimu- 
lation of fatty acid synthesis by (-)-hydroxycitrate; 
this effect may be explained most readily by an 
activation of acetyl-CoA carboxylase (EC 6.4.1.2) as 
known from other tricarboxylates [ 121. The 
(--)-hydroxycitrate stimulation of fatty acid synthesis 
was also observed in the perfused liver if acetate was 
added (fig. 2). It appears that the stimulated fatty 
acid synthesis drains acetylCoA generated by acetyl- 
CoA synthetase off from other acetyl-CoA requiring 
reactions in the cytoplasm, e.g. mevalonate synthesis. 
The reported effect of (-)-hydroxycitrate on 
cholesterol synthesis cannot be explained by an 
impairment of intramitochondrial acetylCoA 
metabolism including HMGCoA synthesis because 
ketone body production was found unchanged. 
These observations suggest hat acetyl-CoA must be 
available in the cytoplasm for an unimpaired cholester- 
ol synthesis in rat liver; this implies the existence of 
an extramitochondrial pathway from acetyl-CoA to 
mevalonate. The fact that cholesterol synthesis was 
not inhibited by avidin nor stimulated by (-)-hydroxy- 
citrate does not support a pathway involving the 
known acetyl-CoA carboxylase reaction. 
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